Advertisement

Activity of the PI3K-δ,γ inhibitor duvelisib in a phase I trial and preclinical models of T-cell lymphoma

Steven M. Horwitz, Raphael Koch, Pierluigi Porcu, Yasuhiro Oki, Alison Moskowitz, Megan Perez, Patricia Myskowski, Adam Officer, Jacob D. Jaffe, Sara N. Morrow, Kerstin Allen, Mark Douglas, Howard Stern, Jennifer Sweeney, Patrick Kelly, Virginia Kelly, Jon C. Aster, David Weaver, Francine M. Foss and David M. Weinstock

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted August 22, 2017
  • Accepted December 1, 2017
  • Published online December 12, 2017.

Article Versions


Contributors 
  • Steven M. Horwitz, 1 Memorial Sloan Kettering Cancer Center, New York, NY, United States;
  • Raphael Koch, 2 Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States;
  • Pierluigi Porcu, 3 The Ohio State University Comprehensive Cancer Center, Columbus, OH, United States;
  • Yasuhiro Oki, 4 MD Anderson Cancer Center, Houston, TX, United States;
  • Alison Moskowitz, 1 Memorial Sloan Kettering Cancer Center, New York, NY, United States;
  • Megan Perez, 1 Memorial Sloan Kettering Cancer Center, New York, NY, United States;
  • Patricia Myskowski, 1 Memorial Sloan Kettering Cancer Center, New York, NY, United States;
  • Adam Officer, 5 Broad Institute of Harvard and MIT, Cambridge, MA, United States;
  • Jacob D. Jaffe, 5 Broad Institute of Harvard and MIT, Cambridge, MA, United States;
  • Sara N. Morrow, 2 Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States;
  • Kerstin Allen, 6 Infinity Pharmaceuticals, Inc., Cambridge, MA, United States;
  • Mark Douglas, 6 Infinity Pharmaceuticals, Inc., Cambridge, MA, United States;
  • Howard Stern, 6 Infinity Pharmaceuticals, Inc., Cambridge, MA, United States;
  • Jennifer Sweeney, 6 Infinity Pharmaceuticals, Inc., Cambridge, MA, United States;
  • Patrick Kelly, 6 Infinity Pharmaceuticals, Inc., Cambridge, MA, United States;
  • Virginia Kelly, 6 Infinity Pharmaceuticals, Inc., Cambridge, MA, United States;
  • Jon C. Aster, 7 Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States;
  • David Weaver, 8 Verastem Pharmaceuticals, Needham, MA, United States;
  • Francine M. Foss, 9 Yale University Cancer Center, New Haven, CT, United States
  • David M. Weinstock, 2 Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, United States;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output